|
| |
DR. DAVID OSBORNE, VP PRODUCT
DEVELOPMENT AT DOW PHARMACEUTICAL SCIENCES, SPEAKS AT SOCIETY FOR INVESTIGATIVE
DERMATOLOGY COURSE IN PHILADELPHIA
October 28, 2004 PETALUMA, CA – Dr. David
Osborne, Vice President of Product Development for Dow Pharmaceutical Sciences,
presented “Principles of Drug Delivery and Skin Metabolism” to over 50
participants at the SID Basics of Skin: Pharmaceutics and Pharmacology Course in
Philadelphia on October 15th, 2004. The Basics of Skin course was developed by
dermatologists who work in both academia and industry and was presented for the
benefit of professionals who work in dermatology research and development in
both the public and private sectors.
Dr. Osborne directs the Formulation Development Group and the Skin Biology and
Drug Delivery laboratory at Dow Pharmaceutical Sciences, a Petaluma, California
company that specializes in development of ethical topical drug products. His
presentation covered: (a) the effect on drug delivery of various topical
formulations including gels, creams, ointments and lotions, (b) basic drug
transport processes and various routes whereby drugs penetrate the skin, (c) the
effect of diseased skin on drug delivery and formulation selection, and (d) how
skin metabolism can facilitate topical therapy using pro-drugs.
In his presentation, Dr. Osborne emphasized how formulation composition and
excipients, the diseased skin, and metabolism within the skin have significant
effects on the amount of drug that penetrates into and through the skin. These
effects are measured quantitatively in Dow’s Skin Biology and Drug Delivery
Laboratory, where both Franz static and Bronough flow-through cells are used to
evaluate client formulations.
About Dow Pharmaceutical Sciences
Dow Pharmaceutical Sciences specializes in the development of dermatology
and other topical products for pharmaceutical and biotechnology clients,
including early stage consultation. They develop and optimize formulations with
the help of their Skin Biology and Drug Delivery Laboratory. Dow also provides
regulatory strategy development, non-clinical and clinical study design and
management, and regulatory filings required to take dermatology products from
inception through FDA approval.
For more information please visit www.dowpharmsci.com
# # #
Contact: Steven R. Smith
Vice President, Marketing & Business Development
1330 Redwood Way, Petaluma, CA 94954
707-665-4672
ssmith@dowpharmsci.com
| |
|
